advertisement
Zhang S 78
Showing records 1 to 25 | Display all abstracts from Zhang S121876 Efficacy and safety of penetrating canaloplasty versus ab externo canaloplasty for primary open-angle glaucoma: A randomized controlled trial
Ye W
Acta Ophthalmologica 2025; 103: e58-e65
123064 Establishment of a CPAMD8-GFP reporter human embryonic stem cell line, IBBDe001-B, using CRISPR/Cas9 editing
Zhang S
Stem cell research 2024; 81: 103615
122755 Inhibition of the rapamycin-insensitive mTORC1 /4E-BP1 axis attenuates TGF-β1-induced fibrotic response in human Tenon's fibroblasts
Zou J
Experimental Eye Research 2024; 244: 109927
120468 ChatGPT for Addressing Patient-centered Frequently Asked Questions in Glaucoma Clinical Practice
Wang H
Ophthalmology. Glaucoma 2024; 0:
121080 Retrocorneal membrane interception enhanced penetrating canaloplasty for patients with open angle glaucoma secondary to ICE syndrome
Zhou M
International Ophthalmology 2024; 44: 395
123440 Acute angle-closure glaucoma before, during, and after the outbreak of COVID-19 in China
Mao Y
Heliyon 2024; 10: e38404
124661 Inhibiting NLRP3 Inflammasome Activation to Alleviate Retinal Inflammation and Protect the Optic Nerve of OPTN(E50K)Mice
Wang S
Inflammation 2024; 0:
119397 Estimates and trends in the global burden of glaucoma influenced by metabolic risk factors from Global Burden of Disease Study between 1990 to 2019
Chen J; Fan H
European Journal of Ophthalmology 2024; 0: 11206721241298022
122755 Inhibition of the rapamycin-insensitive mTORC1 /4E-BP1 axis attenuates TGF-β1-induced fibrotic response in human Tenon's fibroblasts
Wu B
Experimental Eye Research 2024; 244: 109927
121080 Retrocorneal membrane interception enhanced penetrating canaloplasty for patients with open angle glaucoma secondary to ICE syndrome
Zhu S
International Ophthalmology 2024; 44: 395
121876 Efficacy and safety of penetrating canaloplasty versus ab externo canaloplasty for primary open-angle glaucoma: A randomized controlled trial
Li J
Acta Ophthalmologica 2025; 103: e58-e65
124661 Inhibiting NLRP3 Inflammasome Activation to Alleviate Retinal Inflammation and Protect the Optic Nerve of OPTN(E50K)Mice
Xiao R
Inflammation 2024; 0:
120468 ChatGPT for Addressing Patient-centered Frequently Asked Questions in Glaucoma Clinical Practice
Masselos K
Ophthalmology. Glaucoma 2024; 0:
123440 Acute angle-closure glaucoma before, during, and after the outbreak of COVID-19 in China
Xie Y
Heliyon 2024; 10: e38404
123064 Establishment of a CPAMD8-GFP reporter human embryonic stem cell line, IBBDe001-B, using CRISPR/Cas9 editing
Li J
Stem cell research 2024; 81: 103615
124661 Inhibiting NLRP3 Inflammasome Activation to Alleviate Retinal Inflammation and Protect the Optic Nerve of OPTN(E50K)Mice
Lu Y
Inflammation 2024; 0:
123064 Establishment of a CPAMD8-GFP reporter human embryonic stem cell line, IBBDe001-B, using CRISPR/Cas9 editing
Pan W
Stem cell research 2024; 81: 103615
123440 Acute angle-closure glaucoma before, during, and after the outbreak of COVID-19 in China
Li G
Heliyon 2024; 10: e38404
121080 Retrocorneal membrane interception enhanced penetrating canaloplasty for patients with open angle glaucoma secondary to ICE syndrome
Li H
International Ophthalmology 2024; 44: 395
119397 Estimates and trends in the global burden of glaucoma influenced by metabolic risk factors from Global Burden of Disease Study between 1990 to 2019
Yu Q
European Journal of Ophthalmology 2024; 0: 11206721241298022
120468 ChatGPT for Addressing Patient-centered Frequently Asked Questions in Glaucoma Clinical Practice
Tong J
Ophthalmology. Glaucoma 2024; 0:
121876 Efficacy and safety of penetrating canaloplasty versus ab externo canaloplasty for primary open-angle glaucoma: A randomized controlled trial
Zhang S
Acta Ophthalmologica 2025; 103: e58-e65
122755 Inhibition of the rapamycin-insensitive mTORC1 /4E-BP1 axis attenuates TGF-β1-induced fibrotic response in human Tenon's fibroblasts
Tao Y
Experimental Eye Research 2024; 244: 109927
120468 ChatGPT for Addressing Patient-centered Frequently Asked Questions in Glaucoma Clinical Practice
Connor HRM
Ophthalmology. Glaucoma 2024; 0:
121876 Efficacy and safety of penetrating canaloplasty versus ab externo canaloplasty for primary open-angle glaucoma: A randomized controlled trial
Zhu S
Acta Ophthalmologica 2025; 103: e58-e65
